nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A5—Crohn's disease	0.443	1	CbGaD
Valproic Acid—PTGS1—Balsalazide—Crohn's disease	0.0937	0.289	CbGbCtD
Valproic Acid—PTGS1—Mesalazine—Crohn's disease	0.0749	0.231	CbGbCtD
Valproic Acid—SLC22A8—Mercaptopurine—Crohn's disease	0.0646	0.199	CbGbCtD
Valproic Acid—PTGS1—Sulfasalazine—Crohn's disease	0.0419	0.129	CbGbCtD
Valproic Acid—CYP3A5—Sulfasalazine—Crohn's disease	0.0251	0.0775	CbGbCtD
Valproic Acid—CYP2C19—Prednisone—Crohn's disease	0.0162	0.05	CbGbCtD
Valproic Acid—CYP3A4—Prednisone—Crohn's disease	0.00783	0.0242	CbGbCtD
Valproic Acid—UGT1A8—mouth—Crohn's disease	0.00406	0.0707	CbGeAlD
Valproic Acid—UGT2B15—gall bladder—Crohn's disease	0.00382	0.0667	CbGeAlD
Valproic Acid—OGDH—mouth—Crohn's disease	0.00377	0.0658	CbGeAlD
Valproic Acid—UGT1A4—mouth—Crohn's disease	0.00307	0.0536	CbGeAlD
Valproic Acid—UGT1A10—digestive system—Crohn's disease	0.00227	0.0396	CbGeAlD
Valproic Acid—UGT1A6—digestive system—Crohn's disease	0.00211	0.0368	CbGeAlD
Valproic Acid—UGT1A8—digestive system—Crohn's disease	0.0018	0.0313	CbGeAlD
Valproic Acid—HDAC2—mouth—Crohn's disease	0.0017	0.0296	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—Crohn's disease	0.00169	0.0295	CbGeAlD
Valproic Acid—OGDH—digestive system—Crohn's disease	0.00167	0.0291	CbGeAlD
Valproic Acid—UGT1A3—digestive system—Crohn's disease	0.0016	0.0279	CbGeAlD
Valproic Acid—ACADSB—mammalian vulva—Crohn's disease	0.00151	0.0264	CbGeAlD
Valproic Acid—UGT2B15—digestive system—Crohn's disease	0.0015	0.0262	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—Crohn's disease	0.00149	0.026	CbGeAlD
Valproic Acid—UGT1A4—digestive system—Crohn's disease	0.00136	0.0237	CbGeAlD
Valproic Acid—ACADSB—digestive system—Crohn's disease	0.00133	0.0231	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—Crohn's disease	0.00118	0.0206	CbGeAlD
Valproic Acid—UGT1A9—digestive system—Crohn's disease	0.00114	0.0199	CbGeAlD
Valproic Acid—CYP2C18—mammalian vulva—Crohn's disease	0.00114	0.0198	CbGeAlD
Valproic Acid—CYP2C18—digestive system—Crohn's disease	0.000997	0.0174	CbGeAlD
Valproic Acid—HDAC2—epithelium—Crohn's disease	0.000989	0.0172	CbGeAlD
Valproic Acid—OGDH—lymph node—Crohn's disease	0.000954	0.0166	CbGeAlD
Valproic Acid—HDAC2—smooth muscle tissue—Crohn's disease	0.000953	0.0166	CbGeAlD
Valproic Acid—HDAC2—skin of body—Crohn's disease	0.000941	0.0164	CbGeAlD
Valproic Acid—UGT2B7—digestive system—Crohn's disease	0.000919	0.016	CbGeAlD
Valproic Acid—SLC16A1—epithelium—Crohn's disease	0.000879	0.0153	CbGeAlD
Valproic Acid—SLC22A7—digestive system—Crohn's disease	0.000874	0.0152	CbGeAlD
Valproic Acid—HDAC9—lymph node—Crohn's disease	0.000841	0.0147	CbGeAlD
Valproic Acid—HDAC2—lymphoid tissue—Crohn's disease	0.000762	0.0133	CbGeAlD
Valproic Acid—ACADSB—lymph node—Crohn's disease	0.000758	0.0132	CbGeAlD
Valproic Acid—HDAC2—digestive system—Crohn's disease	0.000752	0.0131	CbGeAlD
Valproic Acid—SLC16A1—digestive system—Crohn's disease	0.000669	0.0117	CbGeAlD
Valproic Acid—ALDH5A1—lymph node—Crohn's disease	0.000667	0.0116	CbGeAlD
Valproic Acid—ABAT—lymph node—Crohn's disease	0.000571	0.00995	CbGeAlD
Valproic Acid—SLC22A5—skin of body—Crohn's disease	0.000478	0.00833	CbGeAlD
Valproic Acid—HDAC2—lymph node—Crohn's disease	0.00043	0.00749	CbGeAlD
Valproic Acid—CYP2C19—digestive system—Crohn's disease	0.000424	0.00739	CbGeAlD
Valproic Acid—CYP2B6—skin of body—Crohn's disease	0.000415	0.00723	CbGeAlD
Valproic Acid—PTGS1—epithelium—Crohn's disease	0.000394	0.00687	CbGeAlD
Valproic Acid—SLC22A5—digestive system—Crohn's disease	0.000382	0.00666	CbGeAlD
Valproic Acid—SLC16A1—lymph node—Crohn's disease	0.000382	0.00666	CbGeAlD
Valproic Acid—PTGS1—smooth muscle tissue—Crohn's disease	0.00038	0.00662	CbGeAlD
Valproic Acid—PTGS1—skin of body—Crohn's disease	0.000375	0.00654	CbGeAlD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000361	0.00294	CcSEcCtD
Valproic Acid—Pancreatitis—Azathioprine—Crohn's disease	0.000358	0.00291	CcSEcCtD
Valproic Acid—Necrosis—Prednisone—Crohn's disease	0.000358	0.00291	CcSEcCtD
Valproic Acid—Memory impairment—Prednisone—Crohn's disease	0.000358	0.00291	CcSEcCtD
Valproic Acid—Dry skin—Mesalazine—Crohn's disease	0.000353	0.00287	CcSEcCtD
Valproic Acid—Abdominal pain upper—Mesalazine—Crohn's disease	0.000352	0.00286	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000352	0.00286	CcSEcCtD
Valproic Acid—Abdominal discomfort—Azathioprine—Crohn's disease	0.00035	0.00285	CcSEcCtD
Valproic Acid—Oedema—Mercaptopurine—Crohn's disease	0.000349	0.00283	CcSEcCtD
Valproic Acid—Breast disorder—Mesalazine—Crohn's disease	0.000348	0.00283	CcSEcCtD
Valproic Acid—Pancytopenia—Azathioprine—Crohn's disease	0.000347	0.00282	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000347	0.00282	CcSEcCtD
Valproic Acid—CYP1A2—digestive system—Crohn's disease	0.000346	0.00603	CbGeAlD
Valproic Acid—PTGS1—mammalian vulva—Crohn's disease	0.000342	0.00596	CbGeAlD
Valproic Acid—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000342	0.00277	CcSEcCtD
Valproic Acid—Petechiae—Prednisone—Crohn's disease	0.000341	0.00277	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00034	0.00276	CcSEcCtD
Valproic Acid—Skin disorder—Mercaptopurine—Crohn's disease	0.000339	0.00275	CcSEcCtD
Valproic Acid—Endocrine disorder—Prednisone—Crohn's disease	0.000339	0.00275	CcSEcCtD
Valproic Acid—CYP2B6—lymphoid tissue—Crohn's disease	0.000336	0.00585	CbGeAlD
Valproic Acid—CYP3A5—digestive system—Crohn's disease	0.000334	0.00582	CbGeAlD
Valproic Acid—Dysphagia—Mesalazine—Crohn's disease	0.000333	0.0027	CcSEcCtD
Valproic Acid—Influenza—Mesalazine—Crohn's disease	0.000333	0.0027	CcSEcCtD
Valproic Acid—Anorexia—Mercaptopurine—Crohn's disease	0.000333	0.0027	CcSEcCtD
Valproic Acid—CYP2B6—digestive system—Crohn's disease	0.000332	0.00578	CbGeAlD
Valproic Acid—Eosinophilia—Mesalazine—Crohn's disease	0.00033	0.00268	CcSEcCtD
Valproic Acid—CYP2C9—digestive system—Crohn's disease	0.000328	0.00573	CbGeAlD
Valproic Acid—Pneumonia—Azathioprine—Crohn's disease	0.000328	0.00266	CcSEcCtD
Valproic Acid—Pancreatitis—Mesalazine—Crohn's disease	0.000327	0.00265	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000323	0.00262	CcSEcCtD
Valproic Acid—Contusion—Prednisone—Crohn's disease	0.000322	0.00261	CcSEcCtD
Valproic Acid—Bronchitis—Mesalazine—Crohn's disease	0.00032	0.0026	CcSEcCtD
Valproic Acid—Amenorrhoea—Prednisone—Crohn's disease	0.00032	0.0026	CcSEcCtD
Valproic Acid—Abdominal discomfort—Mesalazine—Crohn's disease	0.000319	0.00259	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000318	0.00258	CcSEcCtD
Valproic Acid—Pancytopenia—Mesalazine—Crohn's disease	0.000316	0.00257	CcSEcCtD
Valproic Acid—Neutropenia—Mesalazine—Crohn's disease	0.000311	0.00253	CcSEcCtD
Valproic Acid—Dysuria—Mesalazine—Crohn's disease	0.000311	0.00253	CcSEcCtD
Valproic Acid—Viral infection—Prednisone—Crohn's disease	0.000311	0.00252	CcSEcCtD
Valproic Acid—Arthropathy—Prednisone—Crohn's disease	0.000309	0.00251	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000308	0.0025	CcSEcCtD
Valproic Acid—Pollakiuria—Mesalazine—Crohn's disease	0.000308	0.0025	CcSEcCtD
Valproic Acid—Agranulocytosis—Azathioprine—Crohn's disease	0.000304	0.00247	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000304	0.00247	CcSEcCtD
Valproic Acid—Decreased appetite—Mercaptopurine—Crohn's disease	0.000303	0.00246	CcSEcCtD
Valproic Acid—Weight increased—Mesalazine—Crohn's disease	0.000303	0.00246	CcSEcCtD
Valproic Acid—Weight decreased—Mesalazine—Crohn's disease	0.000301	0.00245	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000301	0.00245	CcSEcCtD
Valproic Acid—PTGS1—digestive system—Crohn's disease	0.0003	0.00523	CbGeAlD
Valproic Acid—Pneumonia—Mesalazine—Crohn's disease	0.000299	0.00243	CcSEcCtD
Valproic Acid—Depression—Mesalazine—Crohn's disease	0.000296	0.0024	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000294	0.00239	CcSEcCtD
Valproic Acid—Haemoglobin—Azathioprine—Crohn's disease	0.000294	0.00239	CcSEcCtD
Valproic Acid—Haemorrhage—Azathioprine—Crohn's disease	0.000293	0.00238	CcSEcCtD
Valproic Acid—Stomatitis—Mesalazine—Crohn's disease	0.000289	0.00235	CcSEcCtD
Valproic Acid—Urinary tract infection—Mesalazine—Crohn's disease	0.000289	0.00234	CcSEcCtD
Valproic Acid—Conjunctivitis—Mesalazine—Crohn's disease	0.000289	0.00234	CcSEcCtD
Valproic Acid—Vasculitis—Prednisone—Crohn's disease	0.000288	0.00234	CcSEcCtD
Valproic Acid—Sweating—Mesalazine—Crohn's disease	0.000285	0.00231	CcSEcCtD
Valproic Acid—Hiccups—Prednisone—Crohn's disease	0.000281	0.00228	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000281	0.00228	CcSEcCtD
Valproic Acid—Epistaxis—Mesalazine—Crohn's disease	0.00028	0.00227	CcSEcCtD
Valproic Acid—Sinusitis—Mesalazine—Crohn's disease	0.000279	0.00226	CcSEcCtD
Valproic Acid—Agranulocytosis—Mesalazine—Crohn's disease	0.000277	0.00225	CcSEcCtD
Valproic Acid—Erythema multiforme—Azathioprine—Crohn's disease	0.000277	0.00225	CcSEcCtD
Valproic Acid—Body temperature increased—Mercaptopurine—Crohn's disease	0.000276	0.00224	CcSEcCtD
Valproic Acid—Haemoglobin—Mesalazine—Crohn's disease	0.000268	0.00218	CcSEcCtD
Valproic Acid—Rhinitis—Mesalazine—Crohn's disease	0.000267	0.00217	CcSEcCtD
Valproic Acid—Haemorrhage—Mesalazine—Crohn's disease	0.000267	0.00216	CcSEcCtD
Valproic Acid—Pharyngitis—Mesalazine—Crohn's disease	0.000265	0.00215	CcSEcCtD
Valproic Acid—Immune system disorder—Azathioprine—Crohn's disease	0.000264	0.00215	CcSEcCtD
Valproic Acid—Mediastinal disorder—Azathioprine—Crohn's disease	0.000264	0.00214	CcSEcCtD
Valproic Acid—Urinary tract disorder—Mesalazine—Crohn's disease	0.000263	0.00214	CcSEcCtD
Valproic Acid—Oedema peripheral—Mesalazine—Crohn's disease	0.000263	0.00213	CcSEcCtD
Valproic Acid—Chills—Azathioprine—Crohn's disease	0.000263	0.00213	CcSEcCtD
Valproic Acid—Connective tissue disorder—Mesalazine—Crohn's disease	0.000262	0.00213	CcSEcCtD
Valproic Acid—Arrhythmia—Azathioprine—Crohn's disease	0.000261	0.00212	CcSEcCtD
Valproic Acid—Urethral disorder—Mesalazine—Crohn's disease	0.000261	0.00212	CcSEcCtD
Valproic Acid—Alopecia—Azathioprine—Crohn's disease	0.000259	0.0021	CcSEcCtD
Valproic Acid—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000257	0.00209	CcSEcCtD
Valproic Acid—Ecchymosis—Prednisone—Crohn's disease	0.000254	0.00206	CcSEcCtD
Valproic Acid—Erythema multiforme—Mesalazine—Crohn's disease	0.000252	0.00205	CcSEcCtD
Valproic Acid—CYP3A4—digestive system—Crohn's disease	0.00025	0.00437	CbGeAlD
Valproic Acid—Eye disorder—Mesalazine—Crohn's disease	0.000249	0.00202	CcSEcCtD
Valproic Acid—Tinnitus—Mesalazine—Crohn's disease	0.000249	0.00202	CcSEcCtD
Valproic Acid—Hyperkinesia—Prednisone—Crohn's disease	0.000245	0.00199	CcSEcCtD
Valproic Acid—Angiopathy—Mesalazine—Crohn's disease	0.000242	0.00196	CcSEcCtD
Valproic Acid—Euphoric mood—Prednisone—Crohn's disease	0.000241	0.00196	CcSEcCtD
Valproic Acid—Immune system disorder—Mesalazine—Crohn's disease	0.000241	0.00196	CcSEcCtD
Valproic Acid—Mediastinal disorder—Mesalazine—Crohn's disease	0.00024	0.00195	CcSEcCtD
Valproic Acid—Chills—Mesalazine—Crohn's disease	0.000239	0.00194	CcSEcCtD
Valproic Acid—Diarrhoea—Mercaptopurine—Crohn's disease	0.000239	0.00194	CcSEcCtD
Valproic Acid—Ill-defined disorder—Azathioprine—Crohn's disease	0.000236	0.00192	CcSEcCtD
Valproic Acid—Alopecia—Mesalazine—Crohn's disease	0.000236	0.00191	CcSEcCtD
Valproic Acid—Anaemia—Azathioprine—Crohn's disease	0.000235	0.00191	CcSEcCtD
Valproic Acid—Mental disorder—Mesalazine—Crohn's disease	0.000234	0.0019	CcSEcCtD
Valproic Acid—Malaise—Azathioprine—Crohn's disease	0.00023	0.00187	CcSEcCtD
Valproic Acid—Flatulence—Mesalazine—Crohn's disease	0.000229	0.00186	CcSEcCtD
Valproic Acid—Leukopenia—Azathioprine—Crohn's disease	0.000228	0.00185	CcSEcCtD
Valproic Acid—Tension—Mesalazine—Crohn's disease	0.000228	0.00185	CcSEcCtD
Valproic Acid—Dysgeusia—Mesalazine—Crohn's disease	0.000227	0.00185	CcSEcCtD
Valproic Acid—Nervousness—Mesalazine—Crohn's disease	0.000225	0.00183	CcSEcCtD
Valproic Acid—Back pain—Mesalazine—Crohn's disease	0.000224	0.00182	CcSEcCtD
Valproic Acid—Muscle spasms—Mesalazine—Crohn's disease	0.000223	0.00181	CcSEcCtD
Valproic Acid—Vomiting—Mercaptopurine—Crohn's disease	0.000222	0.0018	CcSEcCtD
Valproic Acid—Injury—Prednisone—Crohn's disease	0.000222	0.0018	CcSEcCtD
Valproic Acid—Rash—Mercaptopurine—Crohn's disease	0.00022	0.00179	CcSEcCtD
Valproic Acid—Dermatitis—Mercaptopurine—Crohn's disease	0.00022	0.00178	CcSEcCtD
Valproic Acid—Vision blurred—Mesalazine—Crohn's disease	0.000219	0.00178	CcSEcCtD
Valproic Acid—SLC22A5—lymph node—Crohn's disease	0.000218	0.0038	CbGeAlD
Valproic Acid—Tremor—Mesalazine—Crohn's disease	0.000217	0.00177	CcSEcCtD
Valproic Acid—Increased appetite—Prednisone—Crohn's disease	0.000217	0.00176	CcSEcCtD
Valproic Acid—Amnesia—Prednisone—Crohn's disease	0.000217	0.00176	CcSEcCtD
Valproic Acid—Arthralgia—Azathioprine—Crohn's disease	0.000217	0.00176	CcSEcCtD
Valproic Acid—Myalgia—Azathioprine—Crohn's disease	0.000217	0.00176	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000215	0.00175	CcSEcCtD
Valproic Acid—Ill-defined disorder—Mesalazine—Crohn's disease	0.000215	0.00175	CcSEcCtD
Valproic Acid—Anaemia—Mesalazine—Crohn's disease	0.000214	0.00174	CcSEcCtD
Valproic Acid—Discomfort—Azathioprine—Crohn's disease	0.000214	0.00174	CcSEcCtD
Valproic Acid—Angioedema—Mesalazine—Crohn's disease	0.000212	0.00172	CcSEcCtD
Valproic Acid—Malaise—Mesalazine—Crohn's disease	0.000209	0.0017	CcSEcCtD
Valproic Acid—Vertigo—Mesalazine—Crohn's disease	0.000208	0.00169	CcSEcCtD
Valproic Acid—Lethargy—Prednisone—Crohn's disease	0.000208	0.00169	CcSEcCtD
Valproic Acid—Leukopenia—Mesalazine—Crohn's disease	0.000208	0.00169	CcSEcCtD
Valproic Acid—Nausea—Mercaptopurine—Crohn's disease	0.000207	0.00168	CcSEcCtD
Valproic Acid—Infection—Azathioprine—Crohn's disease	0.000207	0.00168	CcSEcCtD
Valproic Acid—Palpitations—Mesalazine—Crohn's disease	0.000205	0.00167	CcSEcCtD
Valproic Acid—Osteoarthritis—Prednisone—Crohn's disease	0.000204	0.00166	CcSEcCtD
Valproic Acid—Thrombocytopenia—Azathioprine—Crohn's disease	0.000204	0.00165	CcSEcCtD
Valproic Acid—Cough—Mesalazine—Crohn's disease	0.000202	0.00164	CcSEcCtD
Valproic Acid—Skin disorder—Azathioprine—Crohn's disease	0.000202	0.00164	CcSEcCtD
Valproic Acid—Affect lability—Prednisone—Crohn's disease	0.000201	0.00163	CcSEcCtD
Valproic Acid—Hypertension—Mesalazine—Crohn's disease	0.0002	0.00163	CcSEcCtD
Valproic Acid—Psychotic disorder—Prednisone—Crohn's disease	0.000199	0.00162	CcSEcCtD
Valproic Acid—Chest pain—Mesalazine—Crohn's disease	0.000198	0.0016	CcSEcCtD
Valproic Acid—Myalgia—Mesalazine—Crohn's disease	0.000198	0.0016	CcSEcCtD
Valproic Acid—Arthralgia—Mesalazine—Crohn's disease	0.000198	0.0016	CcSEcCtD
Valproic Acid—Anxiety—Mesalazine—Crohn's disease	0.000197	0.0016	CcSEcCtD
Valproic Acid—Face oedema—Prednisone—Crohn's disease	0.000197	0.0016	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000196	0.00159	CcSEcCtD
Valproic Acid—Discomfort—Mesalazine—Crohn's disease	0.000195	0.00158	CcSEcCtD
Valproic Acid—Hypotension—Azathioprine—Crohn's disease	0.000194	0.00158	CcSEcCtD
Valproic Acid—Dry mouth—Mesalazine—Crohn's disease	0.000193	0.00157	CcSEcCtD
Valproic Acid—Mood swings—Prednisone—Crohn's disease	0.000193	0.00157	CcSEcCtD
Valproic Acid—Confusional state—Mesalazine—Crohn's disease	0.000191	0.00155	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000189	0.00154	CcSEcCtD
Valproic Acid—Anaphylactic shock—Mesalazine—Crohn's disease	0.000189	0.00154	CcSEcCtD
Valproic Acid—Oedema—Mesalazine—Crohn's disease	0.000189	0.00154	CcSEcCtD
Valproic Acid—Infection—Mesalazine—Crohn's disease	0.000188	0.00153	CcSEcCtD
Valproic Acid—Dry skin—Prednisone—Crohn's disease	0.000187	0.00152	CcSEcCtD
Valproic Acid—Nervous system disorder—Mesalazine—Crohn's disease	0.000186	0.00151	CcSEcCtD
Valproic Acid—Thrombocytopenia—Mesalazine—Crohn's disease	0.000185	0.00151	CcSEcCtD
Valproic Acid—Tachycardia—Mesalazine—Crohn's disease	0.000185	0.0015	CcSEcCtD
Valproic Acid—Skin disorder—Mesalazine—Crohn's disease	0.000184	0.00149	CcSEcCtD
Valproic Acid—Hyperhidrosis—Mesalazine—Crohn's disease	0.000183	0.00149	CcSEcCtD
Valproic Acid—Anorexia—Mesalazine—Crohn's disease	0.000181	0.00147	CcSEcCtD
Valproic Acid—Muscular weakness—Prednisone—Crohn's disease	0.00018	0.00146	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00018	0.00146	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000179	0.00146	CcSEcCtD
Valproic Acid—Hypotension—Mesalazine—Crohn's disease	0.000177	0.00144	CcSEcCtD
Valproic Acid—Pancreatitis—Prednisone—Crohn's disease	0.000173	0.0014	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000173	0.0014	CcSEcCtD
Valproic Acid—Sweating increased—Prednisone—Crohn's disease	0.000172	0.00139	CcSEcCtD
Valproic Acid—Feeling abnormal—Azathioprine—Crohn's disease	0.000171	0.00139	CcSEcCtD
Valproic Acid—PTGS1—lymph node—Crohn's disease	0.000171	0.00299	CbGeAlD
Valproic Acid—Insomnia—Mesalazine—Crohn's disease	0.000171	0.00139	CcSEcCtD
Valproic Acid—Paraesthesia—Mesalazine—Crohn's disease	0.00017	0.00138	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00017	0.00138	CcSEcCtD
Valproic Acid—Dyspnoea—Mesalazine—Crohn's disease	0.000169	0.00137	CcSEcCtD
Valproic Acid—Somnolence—Mesalazine—Crohn's disease	0.000168	0.00137	CcSEcCtD
Valproic Acid—Dyspepsia—Mesalazine—Crohn's disease	0.000167	0.00135	CcSEcCtD
Valproic Acid—Neutropenia—Prednisone—Crohn's disease	0.000165	0.00134	CcSEcCtD
Valproic Acid—Decreased appetite—Mesalazine—Crohn's disease	0.000165	0.00134	CcSEcCtD
Valproic Acid—Body temperature increased—Azathioprine—Crohn's disease	0.000164	0.00133	CcSEcCtD
Valproic Acid—Abdominal pain—Azathioprine—Crohn's disease	0.000164	0.00133	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000163	0.00133	CcSEcCtD
Valproic Acid—Fatigue—Mesalazine—Crohn's disease	0.000163	0.00133	CcSEcCtD
Valproic Acid—Constipation—Mesalazine—Crohn's disease	0.000162	0.00131	CcSEcCtD
Valproic Acid—Pain—Mesalazine—Crohn's disease	0.000162	0.00131	CcSEcCtD
Valproic Acid—Weight increased—Prednisone—Crohn's disease	0.00016	0.0013	CcSEcCtD
Valproic Acid—Weight decreased—Prednisone—Crohn's disease	0.000159	0.00129	CcSEcCtD
Valproic Acid—Depression—Prednisone—Crohn's disease	0.000157	0.00127	CcSEcCtD
Valproic Acid—Feeling abnormal—Mesalazine—Crohn's disease	0.000156	0.00127	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000155	0.00126	CcSEcCtD
Valproic Acid—Hypersensitivity—Azathioprine—Crohn's disease	0.000153	0.00124	CcSEcCtD
Valproic Acid—Urticaria—Mesalazine—Crohn's disease	0.00015	0.00122	CcSEcCtD
Valproic Acid—Body temperature increased—Mesalazine—Crohn's disease	0.00015	0.00122	CcSEcCtD
Valproic Acid—Abdominal pain—Mesalazine—Crohn's disease	0.00015	0.00122	CcSEcCtD
Valproic Acid—Bradycardia—Prednisone—Crohn's disease	0.000144	0.00117	CcSEcCtD
Valproic Acid—Diarrhoea—Azathioprine—Crohn's disease	0.000142	0.00116	CcSEcCtD
Valproic Acid—Haemoglobin—Prednisone—Crohn's disease	0.000142	0.00115	CcSEcCtD
Valproic Acid—Haemorrhage—Prednisone—Crohn's disease	0.000141	0.00115	CcSEcCtD
Valproic Acid—Hallucination—Prednisone—Crohn's disease	0.00014	0.00114	CcSEcCtD
Valproic Acid—Hypersensitivity—Mesalazine—Crohn's disease	0.00014	0.00113	CcSEcCtD
Valproic Acid—Connective tissue disorder—Prednisone—Crohn's disease	0.000139	0.00113	CcSEcCtD
Valproic Acid—Dizziness—Azathioprine—Crohn's disease	0.000137	0.00112	CcSEcCtD
Valproic Acid—Asthenia—Mesalazine—Crohn's disease	0.000136	0.0011	CcSEcCtD
Valproic Acid—Pruritus—Mesalazine—Crohn's disease	0.000134	0.00109	CcSEcCtD
Valproic Acid—Vomiting—Azathioprine—Crohn's disease	0.000132	0.00107	CcSEcCtD
Valproic Acid—Eye disorder—Prednisone—Crohn's disease	0.000132	0.00107	CcSEcCtD
Valproic Acid—Rash—Azathioprine—Crohn's disease	0.000131	0.00106	CcSEcCtD
Valproic Acid—Dermatitis—Azathioprine—Crohn's disease	0.000131	0.00106	CcSEcCtD
Valproic Acid—Headache—Azathioprine—Crohn's disease	0.00013	0.00106	CcSEcCtD
Valproic Acid—Diarrhoea—Mesalazine—Crohn's disease	0.00013	0.00105	CcSEcCtD
Valproic Acid—Angiopathy—Prednisone—Crohn's disease	0.000128	0.00104	CcSEcCtD
Valproic Acid—Immune system disorder—Prednisone—Crohn's disease	0.000127	0.00103	CcSEcCtD
Valproic Acid—Arrhythmia—Prednisone—Crohn's disease	0.000126	0.00102	CcSEcCtD
Valproic Acid—Dizziness—Mesalazine—Crohn's disease	0.000125	0.00102	CcSEcCtD
Valproic Acid—Alopecia—Prednisone—Crohn's disease	0.000125	0.00101	CcSEcCtD
Valproic Acid—Mental disorder—Prednisone—Crohn's disease	0.000124	0.001	CcSEcCtD
Valproic Acid—Nausea—Azathioprine—Crohn's disease	0.000123	0.001	CcSEcCtD
Valproic Acid—Malnutrition—Prednisone—Crohn's disease	0.000123	0.000997	CcSEcCtD
Valproic Acid—Vomiting—Mesalazine—Crohn's disease	0.00012	0.000978	CcSEcCtD
Valproic Acid—Rash—Mesalazine—Crohn's disease	0.000119	0.00097	CcSEcCtD
Valproic Acid—Dermatitis—Mesalazine—Crohn's disease	0.000119	0.000969	CcSEcCtD
Valproic Acid—Headache—Mesalazine—Crohn's disease	0.000119	0.000963	CcSEcCtD
Valproic Acid—Vision blurred—Prednisone—Crohn's disease	0.000116	0.00094	CcSEcCtD
Valproic Acid—Ill-defined disorder—Prednisone—Crohn's disease	0.000114	0.000925	CcSEcCtD
Valproic Acid—Anaemia—Prednisone—Crohn's disease	0.000113	0.000921	CcSEcCtD
Valproic Acid—Agitation—Prednisone—Crohn's disease	0.000113	0.000916	CcSEcCtD
Valproic Acid—Nausea—Mesalazine—Crohn's disease	0.000112	0.000913	CcSEcCtD
Valproic Acid—Angioedema—Prednisone—Crohn's disease	0.000112	0.000911	CcSEcCtD
Valproic Acid—Malaise—Prednisone—Crohn's disease	0.000111	0.000899	CcSEcCtD
Valproic Acid—Vertigo—Prednisone—Crohn's disease	0.00011	0.000896	CcSEcCtD
Valproic Acid—Hypertension—Prednisone—Crohn's disease	0.000106	0.000861	CcSEcCtD
Valproic Acid—Myalgia—Prednisone—Crohn's disease	0.000105	0.000849	CcSEcCtD
Valproic Acid—Arthralgia—Prednisone—Crohn's disease	0.000105	0.000849	CcSEcCtD
Valproic Acid—Anxiety—Prednisone—Crohn's disease	0.000104	0.000846	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000104	0.000843	CcSEcCtD
Valproic Acid—Discomfort—Prednisone—Crohn's disease	0.000103	0.000839	CcSEcCtD
Valproic Acid—Oedema—Prednisone—Crohn's disease	0.0001	0.000814	CcSEcCtD
Valproic Acid—Anaphylactic shock—Prednisone—Crohn's disease	0.0001	0.000814	CcSEcCtD
Valproic Acid—Infection—Prednisone—Crohn's disease	9.95e-05	0.000808	CcSEcCtD
Valproic Acid—Nervous system disorder—Prednisone—Crohn's disease	9.83e-05	0.000798	CcSEcCtD
Valproic Acid—Tachycardia—Prednisone—Crohn's disease	9.78e-05	0.000794	CcSEcCtD
Valproic Acid—Skin disorder—Prednisone—Crohn's disease	9.73e-05	0.00079	CcSEcCtD
Valproic Acid—Hyperhidrosis—Prednisone—Crohn's disease	9.69e-05	0.000787	CcSEcCtD
Valproic Acid—Anorexia—Prednisone—Crohn's disease	9.55e-05	0.000776	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Prednisone—Crohn's disease	9.13e-05	0.000741	CcSEcCtD
Valproic Acid—Insomnia—Prednisone—Crohn's disease	9.06e-05	0.000736	CcSEcCtD
Valproic Acid—Paraesthesia—Prednisone—Crohn's disease	9e-05	0.000731	CcSEcCtD
Valproic Acid—Dyspepsia—Prednisone—Crohn's disease	8.82e-05	0.000716	CcSEcCtD
Valproic Acid—Decreased appetite—Prednisone—Crohn's disease	8.71e-05	0.000707	CcSEcCtD
Valproic Acid—Fatigue—Prednisone—Crohn's disease	8.64e-05	0.000701	CcSEcCtD
Valproic Acid—Constipation—Prednisone—Crohn's disease	8.57e-05	0.000696	CcSEcCtD
Valproic Acid—Feeling abnormal—Prednisone—Crohn's disease	8.26e-05	0.00067	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Prednisone—Crohn's disease	8.19e-05	0.000665	CcSEcCtD
Valproic Acid—Urticaria—Prednisone—Crohn's disease	7.96e-05	0.000646	CcSEcCtD
Valproic Acid—Abdominal pain—Prednisone—Crohn's disease	7.92e-05	0.000643	CcSEcCtD
Valproic Acid—Body temperature increased—Prednisone—Crohn's disease	7.92e-05	0.000643	CcSEcCtD
Valproic Acid—Hypersensitivity—Prednisone—Crohn's disease	7.38e-05	0.000599	CcSEcCtD
Valproic Acid—Asthenia—Prednisone—Crohn's disease	7.19e-05	0.000584	CcSEcCtD
Valproic Acid—Pruritus—Prednisone—Crohn's disease	7.09e-05	0.000576	CcSEcCtD
Valproic Acid—Diarrhoea—Prednisone—Crohn's disease	6.86e-05	0.000557	CcSEcCtD
Valproic Acid—Dizziness—Prednisone—Crohn's disease	6.63e-05	0.000538	CcSEcCtD
Valproic Acid—Vomiting—Prednisone—Crohn's disease	6.37e-05	0.000517	CcSEcCtD
Valproic Acid—Rash—Prednisone—Crohn's disease	6.32e-05	0.000513	CcSEcCtD
Valproic Acid—Dermatitis—Prednisone—Crohn's disease	6.31e-05	0.000513	CcSEcCtD
Valproic Acid—Headache—Prednisone—Crohn's disease	6.28e-05	0.00051	CcSEcCtD
Valproic Acid—Nausea—Prednisone—Crohn's disease	5.95e-05	0.000483	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—GPX4—Crohn's disease	4.73e-05	0.000898	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—RASGRP1—Crohn's disease	4.71e-05	0.000895	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.71e-05	0.000894	CbGpPWpGaD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.67e-05	0.000886	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCR6—Crohn's disease	4.65e-05	0.000882	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ACKR2—Crohn's disease	4.63e-05	0.000879	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.61e-05	0.000876	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	4.61e-05	0.000876	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	4.6e-05	0.000873	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ITGA4—Crohn's disease	4.57e-05	0.000868	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GCKR—Crohn's disease	4.57e-05	0.000867	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—MTMR3—Crohn's disease	4.46e-05	0.000847	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL3—Crohn's disease	4.46e-05	0.000846	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	4.43e-05	0.000841	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MLN—Crohn's disease	4.39e-05	0.000833	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.36e-05	0.000827	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—RASGRP1—Crohn's disease	4.31e-05	0.000818	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PLA2G4F—Crohn's disease	4.28e-05	0.000812	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	4.28e-05	0.000812	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—LTF—Crohn's disease	4.26e-05	0.000809	CbGpPWpGaD
Valproic Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.2e-05	0.000798	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RBX1—Crohn's disease	4.2e-05	0.000798	CbGpPWpGaD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.17e-05	0.000791	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MTMR3—Crohn's disease	4.16e-05	0.00079	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	4.16e-05	0.00079	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—DNMT3A—Crohn's disease	4.15e-05	0.000788	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—JAK2—Crohn's disease	4.13e-05	0.000784	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.1e-05	0.000779	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTGER4—Crohn's disease	4.09e-05	0.000777	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TAGAP—Crohn's disease	4.01e-05	0.000762	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4e-05	0.000759	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—FADS1—Crohn's disease	3.9e-05	0.000741	CbGpPWpGaD
Valproic Acid—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.89e-05	0.000739	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.85e-05	0.000731	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.84e-05	0.000729	CbGpPWpGaD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.8e-05	0.000721	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—ALB—Crohn's disease	3.79e-05	0.00072	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SMAD3—Crohn's disease	3.76e-05	0.000715	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—UBE2D1—Crohn's disease	3.68e-05	0.0007	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GPX4—Crohn's disease	3.65e-05	0.000693	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MTMR3—Crohn's disease	3.64e-05	0.000691	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	3.62e-05	0.000687	CbGpPWpGaD
Valproic Acid—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.62e-05	0.000686	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RIPK2—Crohn's disease	3.57e-05	0.000678	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.57e-05	0.000678	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MTMR3—Crohn's disease	3.54e-05	0.000672	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GCKR—Crohn's disease	3.53e-05	0.00067	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RSPO3—Crohn's disease	3.51e-05	0.000666	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL3—Crohn's disease	3.48e-05	0.000662	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—FADS1—Crohn's disease	3.48e-05	0.00066	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—TYK2—Crohn's disease	3.47e-05	0.000659	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	3.47e-05	0.000659	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—GCKR—Crohn's disease	3.43e-05	0.000652	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	3.42e-05	0.000649	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL2RA—Crohn's disease	3.41e-05	0.000648	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.4e-05	0.000646	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	3.38e-05	0.000642	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RASGRP1—Crohn's disease	3.37e-05	0.00064	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SEL1L—Crohn's disease	3.33e-05	0.000631	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PTGS2—Crohn's disease	3.32e-05	0.00063	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—JAK2—Crohn's disease	3.31e-05	0.000629	CbGpPWpGaD
Valproic Acid—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.27e-05	0.000621	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GPX4—Crohn's disease	3.26e-05	0.000618	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.25e-05	0.000618	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.25e-05	0.000616	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—FADS1—Crohn's disease	3.24e-05	0.000616	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.23e-05	0.000613	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—ALB—Crohn's disease	3.23e-05	0.000613	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GCKR—Crohn's disease	3.14e-05	0.000597	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL2RA—Crohn's disease	3.12e-05	0.000593	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	3.1e-05	0.000589	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SOCS1—Crohn's disease	3.05e-05	0.00058	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR9—Crohn's disease	3.04e-05	0.000578	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GPX4—Crohn's disease	3.04e-05	0.000576	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SLC11A1—Crohn's disease	3.04e-05	0.000576	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.03e-05	0.000576	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GCKR—Crohn's disease	2.93e-05	0.000557	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MTMR3—Crohn's disease	2.88e-05	0.000546	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—FADS1—Crohn's disease	2.83e-05	0.000538	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GPR65—Crohn's disease	2.83e-05	0.000537	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTGS2—Crohn's disease	2.82e-05	0.000536	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—HSPA1B—Crohn's disease	2.8e-05	0.000532	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.78e-05	0.000528	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.77e-05	0.000525	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PLA2G4F—Crohn's disease	2.76e-05	0.000523	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—FADS1—Crohn's disease	2.76e-05	0.000523	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.73e-05	0.000518	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GPX4—Crohn's disease	2.65e-05	0.000504	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.65e-05	0.000503	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SMAD3—Crohn's disease	2.64e-05	0.000501	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	2.61e-05	0.000495	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HSPA1B—Crohn's disease	2.6e-05	0.000494	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RBX1—Crohn's disease	2.6e-05	0.000494	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GPX4—Crohn's disease	2.58e-05	0.00049	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GCKR—Crohn's disease	2.56e-05	0.000487	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	2.5e-05	0.000475	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GCKR—Crohn's disease	2.49e-05	0.000473	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.48e-05	0.000471	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—ALB—Crohn's disease	2.47e-05	0.000469	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—UBE2D1—Crohn's disease	2.46e-05	0.000467	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TYK2—Crohn's disease	2.46e-05	0.000466	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2RA—Crohn's disease	2.44e-05	0.000463	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—STAT3—Crohn's disease	2.43e-05	0.000462	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.36e-05	0.000449	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.36e-05	0.000449	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MTMR3—Crohn's disease	2.34e-05	0.000445	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—JAK2—Crohn's disease	2.34e-05	0.000445	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.34e-05	0.000445	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.34e-05	0.000445	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—JAK2—Crohn's disease	2.29e-05	0.000436	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—UBE2D1—Crohn's disease	2.28e-05	0.000433	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—ALB—Crohn's disease	2.26e-05	0.000429	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—IL6—Crohn's disease	2.25e-05	0.000428	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—FADS1—Crohn's disease	2.24e-05	0.000425	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CD4—Crohn's disease	2.22e-05	0.000422	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTMR3—Crohn's disease	2.22e-05	0.000421	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.21e-05	0.00042	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—Crohn's disease	2.2e-05	0.000419	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.16e-05	0.000409	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.14e-05	0.000406	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	2.1e-05	0.000399	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—JAK2—Crohn's disease	2.1e-05	0.000398	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GPX4—Crohn's disease	2.1e-05	0.000398	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	2.06e-05	0.00039	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GCKR—Crohn's disease	2.03e-05	0.000385	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.02e-05	0.000383	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCR6—Crohn's disease	2.01e-05	0.000383	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ALB—Crohn's disease	1.99e-05	0.000378	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	1.98e-05	0.000375	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.84e-05	0.00035	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	1.84e-05	0.000349	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—FADS1—Crohn's disease	1.83e-05	0.000347	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RBX1—Crohn's disease	1.82e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTMR3—Crohn's disease	1.79e-05	0.00034	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	1.78e-05	0.000338	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTGER4—Crohn's disease	1.77e-05	0.000337	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—SMAD3—Crohn's disease	1.76e-05	0.000334	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTMR3—Crohn's disease	1.75e-05	0.000332	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—Crohn's disease	1.74e-05	0.000331	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ALB—Crohn's disease	1.74e-05	0.000331	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—FADS1—Crohn's disease	1.73e-05	0.000328	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.72e-05	0.000328	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TYK2—Crohn's disease	1.72e-05	0.000327	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—STAT3—Crohn's disease	1.72e-05	0.000326	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GPX4—Crohn's disease	1.71e-05	0.000325	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IL6—Crohn's disease	1.7e-05	0.000322	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.66e-05	0.000315	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GCKR—Crohn's disease	1.65e-05	0.000314	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—JAK2—Crohn's disease	1.64e-05	0.000312	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SMAD3—Crohn's disease	1.63e-05	0.00031	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GPX4—Crohn's disease	1.62e-05	0.000307	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—UBE2D1—Crohn's disease	1.6e-05	0.000303	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	1.59e-05	0.000302	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GCKR—Crohn's disease	1.56e-05	0.000297	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RIPK2—Crohn's disease	1.55e-05	0.000294	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—Crohn's disease	1.52e-05	0.000289	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.51e-05	0.000287	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL3—Crohn's disease	1.51e-05	0.000287	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CXCL8—Crohn's disease	1.5e-05	0.000284	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RASGRP1—Crohn's disease	1.46e-05	0.000277	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ALB—Crohn's disease	1.45e-05	0.000276	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.45e-05	0.000275	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.45e-05	0.000275	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—FADS1—Crohn's disease	1.39e-05	0.000265	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.39e-05	0.000263	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—FADS1—Crohn's disease	1.36e-05	0.000259	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTMR3—Crohn's disease	1.35e-05	0.000257	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SOCS1—Crohn's disease	1.32e-05	0.000251	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX4—Crohn's disease	1.3e-05	0.000248	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX4—Crohn's disease	1.28e-05	0.000242	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—Crohn's disease	1.27e-05	0.000242	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.27e-05	0.00024	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GCKR—Crohn's disease	1.26e-05	0.000239	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.24e-05	0.000235	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.23e-05	0.000234	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GCKR—Crohn's disease	1.23e-05	0.000234	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—STAT3—Crohn's disease	1.2e-05	0.000229	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—Crohn's disease	1.2e-05	0.000228	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.18e-05	0.000224	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—FADS1—Crohn's disease	1.18e-05	0.000224	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMAD3—Crohn's disease	1.14e-05	0.000217	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ALB—Crohn's disease	1.12e-05	0.000213	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX4—Crohn's disease	1.1e-05	0.00021	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GCKR—Crohn's disease	1.07e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TYK2—Crohn's disease	1.06e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2RA—Crohn's disease	1.06e-05	0.000201	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.05e-05	0.0002	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—FADS1—Crohn's disease	1.05e-05	0.0002	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.03e-05	0.000196	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—JAK2—Crohn's disease	1.02e-05	0.000193	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ALB—Crohn's disease	1e-05	0.00019	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX4—Crohn's disease	9.86e-06	0.000187	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—Crohn's disease	9.82e-06	0.000186	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CD4—Crohn's disease	9.63e-06	0.000183	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—FADS1—Crohn's disease	9.6e-06	0.000182	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—Crohn's disease	9.56e-06	0.000182	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	9.56e-06	0.000181	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GCKR—Crohn's disease	9.52e-06	0.000181	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ALB—Crohn's disease	9.33e-06	0.000177	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX4—Crohn's disease	8.99e-06	0.000171	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—Crohn's disease	8.75e-06	0.000166	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GCKR—Crohn's disease	8.68e-06	0.000165	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—Crohn's disease	8.41e-06	0.00016	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—FADS1—Crohn's disease	8.2e-06	0.000156	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—Crohn's disease	8.16e-06	0.000155	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ALB—Crohn's disease	8.16e-06	0.000155	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTMR3—Crohn's disease	8.13e-06	0.000154	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ALB—Crohn's disease	7.93e-06	0.000151	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX4—Crohn's disease	7.68e-06	0.000146	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.62e-06	0.000145	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TYK2—Crohn's disease	7.46e-06	0.000142	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—Crohn's disease	7.46e-06	0.000142	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GCKR—Crohn's disease	7.42e-06	0.000141	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—Crohn's disease	7.14e-06	0.000135	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JAK2—Crohn's disease	7.11e-06	0.000135	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—Crohn's disease	6.94e-06	0.000132	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.8e-06	0.000129	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.67e-06	0.000127	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—Crohn's disease	6.49e-06	0.000123	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—Crohn's disease	6.45e-06	0.000122	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FADS1—Crohn's disease	6.33e-06	0.00012	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.2e-06	0.000118	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.95e-06	0.000113	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX4—Crohn's disease	5.93e-06	0.000113	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GCKR—Crohn's disease	5.73e-06	0.000109	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—Crohn's disease	5.64e-06	0.000107	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.43e-06	0.000103	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.3e-06	0.000101	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—Crohn's disease	5.26e-06	9.98e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—Crohn's disease	5.22e-06	9.91e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—Crohn's disease	5.21e-06	9.89e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—Crohn's disease	4.97e-06	9.44e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.64e-06	8.81e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—Crohn's disease	4.6e-06	8.73e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—Crohn's disease	4.35e-06	8.26e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—Crohn's disease	4.01e-06	7.61e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—Crohn's disease	3.92e-06	7.44e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—Crohn's disease	3.65e-06	6.92e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—Crohn's disease	3.51e-06	6.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.43e-06	6.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—Crohn's disease	3.4e-06	6.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—Crohn's disease	3.03e-06	5.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—Crohn's disease	2.97e-06	5.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—Crohn's disease	2.76e-06	5.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—Crohn's disease	2.65e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.42e-06	4.59e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—Crohn's disease	2.36e-06	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.07e-06	3.92e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—Crohn's disease	1.82e-06	3.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.59e-06	3.03e-05	CbGpPWpGaD
